How reliable are tests for trachoma? - A latent class approach

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 9, 2011, Pages 6133-6137

  See, Craig W ^a   Alemayehu, Wondu ^b   Melese, Muluken ^b   Zhou, Zhaoxia ^a   Porco, Travis C ^a   Shiboski, Stephen ^a   Gaynor, Bruce D ^a   Eng, John ^c   Keenan, Jeremy D ^a   Lietman, Thomas M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ORBIS INTERNATIONAL   (Ethiopia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ETHIOPIA; EYE INFECTION; FOLLICULAR TRACHOMA; HUMAN; INTENSE TRACHOMATOUS INFLAMMATION; LATENT CLASS ANALYSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TRACHOMA;

CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DNA, BACTERIAL; ETHIOPIA; HUMANS; INFANT; POLYMERASE CHAIN REACTION; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRACHOMA;

EID: 80051516705     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7419     Document Type: Article

References (40)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82(11):844-851
2. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354(9179):630-635.
3. Solomon AW, Peeling RW, Foster A, Mabey DCW. Diagnosis and assessment of trachoma (review). Clin Microbiol Rev. 2004;17(4): 982-1011.
4. World Health Organization. Report of the Eighth Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. Geneva, WHO; 2004.
5. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med. 1999;5(5):572-576.
6. Melese M, Alemayehu W, Lakew T, et al. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA. 2008;299(7):778-784.
7. Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004;292(6):721-725.
8. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477-483.
9. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342(8869):453-456.
10. Bailey RL, Hampton TJ, Hayes LJ, et al. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. J Infect Dis. 1994;170(3):709-712.
11. Chidambaram JD, Alemayehu W, Melese M, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006;295(10):1142-1146.
12. Yang JL, Hong KC, Schachter J, et al. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification. Invest Ophthalmol Vis Sci. 2009;50(1):90-94.
13. Yang JL, Schachter J, Moncada J, et al. Comparison of an rRNAbased and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br J Ophthalmol. 2007;91(3):293-295.
14. Baral K, Osaki S, Shreshta B, et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull World Health Organ. 1999;77(6):461-466.
15. Bird M, Dawson CR, Schachter JS, et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma- endemic areas? J Infect Dis. 2003;187(10):1669-1673.
16. Bobo LD, N. Novak, B. Munoz, et al. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis. 1997;176(6):1524-1530.
17. Holm SO, Jha HC, Bhatta RC, et al. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull World Health Organ. 2001;79(3):194-200.
18. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004; 351(19):1962-1971.
19. Thein J, Zhao P, Liu H, et al. Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma? Ophthalmic Epidemiol. 2002;9(4):263-269.
20. Goodman LA. Exploratory latent structure-analysis using both identifiable and unidentifiable models. Biometrika. 1974;61(2):215-231.
21. Kullback S, Leibler RA. On information and sufficiency. Ann Math Stat. 1951;22(1):79-86.
22. Formann AK, Kohlmann T. Latent class analysis in medical research. Stat Methods Med Res. 1996;5(2):179-211.
23. Miller K, Schmidt G, Melese M, et al. How reliable is the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiol. 2004;11(3):255-262.
24. Solomon AW, Holland MJ, Burton MJ, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet. 2003;362(9379):198-204.
25. Taylor HR, Johnson SL, Prendergast RA, et al. An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci. 1982;23(4):507-515.
26. Grassly NC, Ward ME, S Ferris, Mabey DC, Bailey RL. The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. PLoS Negl Trop Dis. 2008;2(12):e341.
27. Bianchi A, Scieux C, Brunat N, et al. An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis. 1994;21(4): 196-200.
28. Lowe P, O'Loughlin P, Evans K, et al. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women. J Clin Microbiol. 2006; 44(7):2619-2621.
29. Puolakkainen M, Hiltunen-Back E, Reunala T, et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol. 1998;36(6):1489-1493.
30. Stothard DR, Williams JA, Van Der Pol B, Jones RB. Identification of a Chlamydia trachomatis serovar E urogenital isolate which lacks the cryptic plasmid. Infect Immun. 1998;66(12):6010-6013.
31. Dean D, Kandel RP, Adhikari HK, Hessel T. Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control. PLoS Med. 2008;5(1):e14.
32. Goldschmidt P, Rostane H, Sow M, et al. Detection by broad-range real-time PCR assay of Chlamydia species infecting human and animals. Br J Ophthalmol. 2006;90(11):1425-1429.
33. de Barbeyrac B, Goldschmidt P, Malembic S, et al. Quality assessment of conjunctival specimens for detection of Chlamydia trachomatis by PCR in children with active trachoma. Clin Microbiol Infect. 2007;13(7):689-694.
34. Alonzo TA, Pepe MS. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat Med. 1999; 18(22):2987-3003.
35. Hadgu A, Miller W, Using a combination of reference tests to assess the accuracy of a diagnostic test by A. Alonzo and M. Pepe. Stat Med. 1999;18: 2987-3003. Stat Med. 2001;20(4):656-660.
36. Pepe MS, Janes H. Insights into latent class analysis of diagnostic test performance. Biostatistics. 2007;8(2):474-484.
37. Hagenaars JA. Latent structure models with direct effects between indicators: local dependence models. Sociol Methods Res. 1988; 16(3):379-405.
38. Qu Y, Tan M, Kutner MH. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics. 1996;52(3):797-810.
39. Uebersax JS. Probit latent class analysis with dichotomous or ordered category measures: conditional independence/dependence models. Appl Psychol Measure. 1999;23(4):283-297.
40. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect. 1999;123(3):479-486.